Last reviewed · How we verify
Rifaximin 550 MG
Rifaximin 550 MG is a Small molecule drug developed by Bonderup, Ole K., M.D.. It is currently FDA-approved. Also known as: Xifaxan, Rifaxa 550MG, Nimixa 550 MG, Xifaxa 550MG.
At a glance
| Generic name | Rifaximin 550 MG |
|---|---|
| Also known as | Xifaxan, Rifaxa 550MG, Nimixa 550 MG, Xifaxa 550MG, Zerifax 550MG |
| Sponsor | Bonderup, Ole K., M.D. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility (PHASE3)
- Rifaximin in Patients With Diabetic Gastroparesis (PHASE2)
- Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis (PHASE3)
- Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation (PHASE1, PHASE2)
- Rifaximin for the Secondary Prevention of Recurrent Pouchitis (PHASE4)
- Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis (PHASE2, PHASE3)
- BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE (PHASE4)
- Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rifaximin 550 MG CI brief — competitive landscape report
- Rifaximin 550 MG updates RSS · CI watch RSS
- Bonderup, Ole K., M.D. portfolio CI
Frequently asked questions about Rifaximin 550 MG
What is Rifaximin 550 MG?
Rifaximin 550 MG is a Small molecule drug developed by Bonderup, Ole K., M.D..
Who makes Rifaximin 550 MG?
Rifaximin 550 MG is developed and marketed by Bonderup, Ole K., M.D. (see full Bonderup, Ole K., M.D. pipeline at /company/bonderup-ole-k-m-d).
Is Rifaximin 550 MG also known as anything else?
Rifaximin 550 MG is also known as Xifaxan, Rifaxa 550MG, Nimixa 550 MG, Xifaxa 550MG, Zerifax 550MG.
What development phase is Rifaximin 550 MG in?
Rifaximin 550 MG is FDA-approved (marketed).
Related
- Manufacturer: Bonderup, Ole K., M.D. — full pipeline
- Also known as: Xifaxan, Rifaxa 550MG, Nimixa 550 MG, Xifaxa 550MG, Zerifax 550MG
- Compare: Rifaximin 550 MG vs similar drugs
- Pricing: Rifaximin 550 MG cost, discount & access